- $279.42m
- $267.83m
- $224.26m
- 97
- 44
- 45
- 66
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.8 | ||
| PEG Ratio (f) | 0.52 | ||
| EPS Growth (f) | 47.7% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.13 | ||
| Price to Tang. Book | 2.86 | ||
| Price to Free Cashflow | 212 | ||
| Price to Sales | 1.25 | ||
| EV to EBITDA | 6.19 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 12.81% | ||
| Return on Equity | 9.19% | ||
| Operating Margin | 7.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 131.31 | 117.06 | 138.83 | 183.01 | 224.26 | 259.91 | 287.9 | 22.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +231.76 | -68.63 | -30.15 | +63.28 | -8.27 | +54.18 | +38.67 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.
Directors
- Randy Dobbs NEC (70)
- Michael Moore PRE (43)
- Casey Hoyt CEO (43)
- Trae Fitzgerald CFO (33)
- W. Todd Zehnder COO (45)
- Jerome Cambre VPR (50)
- Patrick Eagan GCN (42)
- William Frazier OTH (62)
- Bruce Greenstein IND (52)
- Sabrina Heltz IND (56)
- Nitin Kaushal IND (56)
- Timothy Smokoff IND (56)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- December 14th, 2016
- Public Since
- December 22nd, 2017
- No. of Employees
- 1,179
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 39,521,618
- Address
- 625 E. KALISTE SALOOM RD., LAFAYETTE, 70508
- Web
- https://www.viemed.com/
- Phone
- +1 3375043802
- Contact
- Glen Akselrod
- Auditors
- Ernst & Young LLP
Upcoming Events for VMD
Q1 2025 Viemed Healthcare Inc Earnings Call
Viemed Healthcare Inc Extraordinary Shareholders Meeting
Viemed Healthcare Inc Annual Shareholders Meeting
Viemed Healthcare Inc Annual Shareholders Meeting
Q2 2025 Viemed Healthcare Inc Earnings Release
Similar to VMD
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
Basel Medical
NASDAQ Capital Market
FAQ
What is the Viemed Healthcare share price?
As of Today at 23:59 UTC, shares in Viemed Healthcare are trading at $7.07. This share price information is delayed by 15 minutes.
How has the Viemed Healthcare share price performed this year?
Shares in Viemed Healthcare last closed at $7.07 and the price had moved by -11.74% over the past 365 days. In terms of relative price strength the Viemed Healthcare share price has underperformed the S&P500 Index by -18.53% over the past year.
What are the analyst and broker recommendations for Viemed Healthcare?
The overall consensus recommendation for Viemed Healthcare is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Viemed Healthcare dividend yield?
Viemed Healthcare does not currently pay a dividend.
Does Viemed Healthcare pay a dividend?
Viemed Healthcare does not currently pay a dividend.
When does Viemed Healthcare next pay dividends?
Viemed Healthcare does not currently pay a dividend.
How do I buy Viemed Healthcare shares?
To buy shares in Viemed Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Viemed Healthcare?
As of the previous close price of $7.07, shares in Viemed Healthcare had a market capitalisation of $279.42m.
Where are Viemed Healthcare shares listed?
Here are the trading details for Viemed Healthcare:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: VMD
What kind of share is Viemed Healthcare?
Based on an overall assessment of its quality, value and momentum Viemed Healthcare is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Viemed Healthcare share price forecast for 2025?
The analyst consensus target price for shares in Viemed Healthcare is $12.83. That is 81.41% above the last closing price of $7.07.
Analysts covering Viemed Healthcare currently have a consensus Earnings Per Share (EPS) forecast of $0.37 for the next financial year.
Find out moreWhat is the trend in the Viemed Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Viemed Healthcare. Over the past six months, its share price has underperformed the S&P500 Index by -19.35%.
As of the last closing price of $7.07, shares in Viemed Healthcare were trading -9.75% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Viemed Healthcare PE Ratio?
The Viemed Healthcare PE ratio based on its reported earnings over the past 12 months is 16.8. The shares last closed at $7.07.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Viemed Healthcare?
Viemed Healthcare's management team is headed by:
- Randy Dobbs - NEC
- Michael Moore - PRE
- Casey Hoyt - CEO
- Trae Fitzgerald - CFO
- W. Todd Zehnder - COO
- Jerome Cambre - VPR
- Patrick Eagan - GCN
- William Frazier - OTH
- Bruce Greenstein - IND
- Sabrina Heltz - IND
- Nitin Kaushal - IND
- Timothy Smokoff - IND